Author

Nicoletta Pirotta

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

2000 · Leonard B. Saltz, John V. Cox, et al. · New England Journal of Medicine · 3,005

Irinotecan Plus Fluorouracil/Leucovorin for Metastatic Colorectal Cancer: A New Survival Standard

2001 · Leonard B. Saltz, Jean-Yves Douillard, et al. · The Oncologist · 147

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy

2011 · Viktor Grünwald, Pierre I. Karakiewicz, et al. · European Journal of Cancer · 86

Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer

2014 · Bernard Escudier, Viktor Grünwald, et al. · Clinical Cancer Research · 57

Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA).

1993 · G Cataldo, M Braga, et al. · PubMed · 43

Phase 1 and Pharmacokinetic Study of Intravenous Irinotecan in Refractory Solid Tumor Patients with Hepatic Dysfunction

2006 · Larry J. Schaaf, Lisa A. Hammond, et al. · Clinical Cancer Research · 38

Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: an open-label phase 1b study

2013 · Jun Guo, Yiran Huang, et al. · BMC Cancer · 32

Estrogen suppression in premenopausal women following 8 weeks of treatment with exemestane and triptorelin versus triptorelin alone

2008 · Maria Gabriella Jannuzzo, Enrico Di Salle, et al. · Breast Cancer Research and Treatment · 30

Phase I Trial of the Combination of Irinotecan, Paclitaxel, and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

2001 · Mark A. Socinski, Alan B. Sandler, et al. · Journal of Clinical Oncology · 20

Early bactericidal activity of rifabutin versus that of placebo in treatment of disseminated Mycobacterium avium complex bacteremia in AIDS patients

1996 · B Dautzenberg, P Castellani, et al. · Antimicrobial Agents and Chemotherapy · 18

Indobufen versus aspirin plus dipyridamole after coronary artery bypass surgery

1991 · F Rovelli, L Campolo, et al. · Coronary Artery Disease · 18

Rifabutin Versus Placebo in Combination with Three Drugs in the Treatment of Nontuberculous Mycobacterial Infection in Patients with AIDS

1996 · B. Dautzenberg, P. Olliaro, et al. · Clinical Infectious Diseases · 11

Estrogen suppression of 8-week treatment with exemestane combined with triptorelin versus triptorelin alone in healthy premenopausal women

2004 · M. G. Jannuzzo, E. Di Salle, et al. · Journal of Clinical Oncology · 6

Irinotecan (CPT-11) in Triplet Combinations in Patients with Advanced Non–Small-Cell Lung Cancer: A Review and Report of a Phase I/II Trial

2001 · Mark A. Socinski, Alan B. Sandler, et al. · Clinical Lung Cancer · 4

“Within patient”—dependent outcomes in graft occlusion after coronary artery bypass

1993 · Ettore Marubini, Mario Braga, et al. · Controlled Clinical Trials · 4

Dovitinib as second-line therapy in patients with fibroblast growth factor receptor 2 (FGFR2)-mutated or non-mutated advanced and/or metastatic endometrial cancer (EC): A single-arm, multicenter, phase II study.

2013 · Gottfried E. Konecny, Neil Finkler, et al. · Journal of Clinical Oncology · 2

Pillar-1: Multicenter Phase 2 Study of Everolimus for Patients with Mantle Cell Lymphoma Who Are Refractory or Intolerant to Bortezomib.

2012 · Michael Wang, Leslie Popplewell, et al. · Blood · 1

Supplementary Figure 1 from Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer

2023 · Bernard Escudier, Viktor Grünwald, et al.

Supplementary Figure Legend from Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer

2023 · Bernard Escudier, Viktor Grünwald, et al.

Supplementary Table 1 from Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer

2023 · Bernard Escudier, Viktor Grünwald, et al.

Supplementary Table 2 from Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer

2023 · Bernard Escudier, Viktor Grünwald, et al.

Supplementary Table 1 from Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer

2023 · Bernard Escudier, Viktor Grünwald, et al.

Supplementary Figure Legend from Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer

2023 · Bernard Escudier, Viktor Grünwald, et al.

Supplementary Table 2 from Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer

2023 · Bernard Escudier, Viktor Grünwald, et al.

Supplementary Figure 1 from Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer

2023 · Bernard Escudier, Viktor Grünwald, et al.

Works count: 28

Citation count: 3,522

H-index: 11

I10-index: 12